Skip to main content

Home > Releases > Quarterly Financial Report > Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Cash Dividends Charged to Retained Earnings This Quarter

Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Cash Dividends Charged to Retained Earnings This Quarter (QFR120385USNO)

Q4 2024: 24,427
Updated: Mar 24, 2025 9:08 AM CDT
Q4 2024:  24,427  
Q3 2024:  12,773  
Q2 2024:  18,642  
Q1 2024:  11,691  
Q4 2023:  20,584  

Units:

Millions of Dollars,
Not Seasonally Adjusted

Frequency:

Quarterly

Fullscreen

Notes

Title Release Dates

2017-09-06 2025-03-24
 
Source    

2017-09-06 2025-03-24
 
Release    

2017-09-06 2025-03-24
 
Units    

2017-09-06 2025-03-24
 
Frequency    

2017-09-06 2025-03-24
 
Seasonal Adjustment    

2017-09-06 2025-03-24
 
Notes    

2017-09-06 2025-03-24

Related Data and Content

Data Suggestions Based On Your Search

Content Suggestions

Related Categories

Releases

Tags